flow trial semaglutide kidney outcomes results 2024 Amelia Carro — Instituto Corvilud on X: "FLOW stopped early due to evidence of renal protection with 📌GLP1ar show cardio-nephro-metabolic effects 📌Semaglutide has already settled its role further than antidiabetic FLOW: Semaglutide Scores Big in

Los resultados mejorados de la enfermedad pronto pueden extenderse a otras afecciones

The study measured what researchers call biological age, distinct from chronological age, using markers known as epigenetic clocks

Related Reading Are Glp 1 Pills Safe Plexusdx Can You Get Your Glp 1 Tested Maximus Glp 1 Found Glp 1 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims

However, heterogeneity was high for the IV subgroup (I 2 = 52%), and the oral subgroup contained homogeneous studies (I 2 = 0%) (Table 3)

Good Start | Dr